Akanda (AKAN) Current Leases (2020 - 2025)

Akanda's (AKAN) quarterly Current Leases came in at $187442.0 in Q4 2025, up 37.74% quarter-over-quarter from $136087.0 in Q2 2025.

Akanda (AKAN) Current Leases (2020 - 2025) Analysis & Trends

Akanda's Current Leases history runs 6 years deep, the most recent figure standing at $187442.0 for Q4 2025.

  • On a quarterly basis, Current Leases changed N/A year-over-year to $187442.0 in Q4 2025; TTM through Dec 2025 was $187442.0, a N/A change from a year earlier, with the FY2025 full-year figure at $187442.0, changed N/A from the prior year.
  • Current Leases climbed to $187442.0 in Q4 2025 per AKAN's latest filing, from $136087.0 in the prior quarter.
  • Across five years, Current Leases topped out at $439709.0 in Q4 2021 and bottomed at $19831.0 in Q2 2024.
  • The 5-year median for Current Leases is $187442.0 (2025), against an average of $193961.3.
  • Across the five-year window, Current Leases plunged 91.2% in 2024 and jumped 586.23% in 2025, its largest moves.
  • Year by year, Current Leases stood at $439709.0 in 2021, then slumped by 51.32% to $214058.0 in 2022, then tumbled by 36.78% to $135337.0 in 2023, then plunged by 85.35% to $19831.0 in 2024, then jumped by 845.2% to $187442.0 in 2025.
  • Per Business Quant, the three latest AKAN Current Leases figures stand at $187442.0 (Q4 2025), $136087.0 (Q2 2025), and $19831.0 (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Akanda 556,353.85 556,353.85 - 187,442.00

Historic Data

Download Data
DateValue
Dec 31, 2025 187,442.00
Jun 30, 2025 136,087.00
Jun 30, 2024 19,831.00
Dec 31, 2023 135,337.00
Jun 30, 2023 225,265.00
Dec 31, 2022 214,058.00
Dec 31, 2021 439,709.00
Dec 31, 2020 283,976.00